The initial oncogenic event in CRC is defined by a mutation targeting the adenomatous polyposis coli (APC) gene, a well‐known tumor‐suppressor gene [11] that provokes the development of benign adenomas or colorectal polyps. Here, APC is linked to neoplasm.